Wellness Marketplace Integration India 2026 — 1mg, Netmeds, PharmEasy | ICG

Author: Abhash Kumar · Co-Founder, ICG · IIT BHU + IIM Bangalore · July 2026

India's online health marketplace landscape has consolidated around five dominant platforms: Tata 1mg, Netmeds (Reliance), PharmEasy (acquired and restructuring), Nykaa Health, and Amazon Health. Each has a different audience, a different product mix, and different advertising mechanisms. Brands that treat them as a single channel are leaving money on the table.

The 5 platforms: audience and product fit

Tata 1mg:

• Audience: health-conscious, moderately urban, value-aware. Strong in diagnostics (home collection), prescription medicines, OTC, and health devices.
• Best for: OTC medicines, nutraceuticals with clinical backing, diagnostics, health devices, and Rx medicine delivery.
• Advertising: 1mg Sponsored Products (keyword-based, similar to Amazon), Brand Store pages, sponsored health content articles.
• FSSAI compliance: 1mg requires FSSAI licence documentation for all supplement and nutraceutical listings. Claim compliance is checked by 1mg's compliance team before listing goes live.

Netmeds (Reliance):

• Audience: mass-market, price-sensitive. Stronger in Tier 2-3 cities than 1mg. Prescription medicines a major category.
• Best for: mass-market OTC brands, generic supplement brands, Rx medicine delivery for cost-sensitive customers.
• Advertising: Netmeds sponsored placement (less sophisticated than 1mg's advertising platform).
• FSSAI compliance: same documentation requirements as 1mg.

PharmEasy:

• In post-restructuring mode as of 2026. Audience and traffic metrics are in flux. ICG monitors position quarterly.
• Best for: maintaining listing presence during restructuring; less emphasis on sponsored investment until platform stabilises.

Nykaa Health:

• Audience: beauty-and-wellness consumer (primarily female, 22-42, urban, premium-inclined). Crossover between beauty consumer and health consumer.
• Best for: dermacosmetics, skin supplements (collagen, biotin, beauty-from-within), women's health supplements, premium Ayurveda brands.
• Advertising: Nykaa Sponsored Brands and Products, Brand Store pages, Nykaa email/push notification features.
• Highest-margin marketplace for premium health brands that overlap with beauty.

Amazon Health:

• Audience: broadest reach. Health supplements are the fastest-growing Amazon India category.
• Best for: protein supplements, vitamins, immunity supplements, health devices. High volume, high competition, margin pressure.
• Advertising: Sponsored Products (keyword PPC), Sponsored Brands (brand header), Sponsored Display (remarketing), Amazon DSP (programmatic display).

Listing optimisation principles (across all platforms)

Title structure: [Brand] + [Product name] + [Key benefit/ingredient] + [Format] + [Size] Example: "WellBrand Ashwagandha KSM-66 — Stress Support Supplement — 60 Veg Capsules"

Bullet points: 5 bullets. Structure: (1) Key active ingredient + standardisation. (2) FSSAI-compliant primary benefit claim. (3) Quality certification (FSSAI, ISO, third-party tested). (4) Format and directions. (5) Who it is for.

FSSAI compliance in listing: Every health claim in the title, bullets, and description must be FSSAI-compliant. Disease-cure claims are removed. Health function claims are acceptable with appropriate qualification ("helps support", "contributes to normal", "may help maintain").

Images: 7 images minimum on 1mg and Amazon Health. Main image: product on white background (required). Additional images: ingredient callouts, clinical backing summary, lifestyle imagery, nutritional information, third-party certification logos.

Reviews: Authentic review generation within platform policies. Amazon Vine programme for Amazon. 1mg's own product review programme for 1mg. No incentivised reviews.

Sponsored advertising on health marketplaces

1mg Sponsored Products: Keyword-based PPC. Target: branded keywords (own brand name), category keywords (supplement category), ingredient keywords (ashwagandha, vitamin C). Bid strategy: manual bidding initially, transition to auto-targeting after 4-6 weeks of data collection.

Amazon Sponsored Products + Brands: The most mature health marketplace advertising platform in India. ICG's Amazon health account management includes: keyword research (Amazon-specific search volume data), negative keyword lists (preventing spend on irrelevant supplement categories), bid optimisation (target ACOS — Advertising Cost of Sale — of 15-25% for most supplement brands), and A+ Content optimisation (brand-registered sellers can use enhanced product pages).

ROAS benchmarks for health marketplace advertising (ICG portfolio data):

FAQ

Q1: Should a new supplement brand launch on Amazon or their own D2C site first? Amazon first — it provides validation (which products sell, which price points work) and cash flow (Amazon pays within 7 days of delivery) without the significant upfront investment of D2C site development and advertising. Once a product has demonstrated Amazon traction (100+ reviews, consistent ACOS below target), invest in D2C site for subscription economics and brand equity. The D2C site built on proven Amazon-validated products performs significantly better than one built on unvalidated products.

Q2: How does FSSAI compliance work for marketplace listings? 1mg and Amazon India both have their own listing compliance teams that review health supplement claims before a listing goes live. A listing with non-compliant health claims (disease cure claims, prohibited benefit claims) will be delisted or prevented from going live. ICG's FSSAI claim review process (using the claim hierarchy table from Article 47) is applied to all marketplace listing content before submission — preventing the listing rejection delay.

Q3: Is PharmEasy still worth investing in given the restructuring? As of Q2 2026: ICG recommends maintaining basic listing presence on PharmEasy (ensures brand is available to existing PharmEasy users) but reducing sponsored advertising investment until the platform stabilises. PharmEasy's audience is intact even during business restructuring — but advertising platform reliability has been variable.

Compliance note: FSSAI Advertising Regulations, DMRA Act, Amazon India Restricted Products Policy, 1mg listing policies.